Switching from tenofovir alafenamide to tenofovir disoproxil fumarate improves lipid profile and protects from weight gain

替诺福韦-阿拉芬酰胺 替诺福韦 医学 药理学 诺如病毒 人类免疫缺陷病毒(HIV) 化学 病毒学 病毒载量 抗逆转录病毒疗法 病毒
作者
Kai Juhani Kauppinen,Inka Aho,Jussi Sutinen
出处
期刊:AIDS [Lippincott Williams & Wilkins]
卷期号:36 (10): 1337-1344 被引量:28
标识
DOI:10.1097/qad.0000000000003245
摘要

Background: Switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) increases low-density lipoprotein cholesterol (LDL-C) and body weight. Metabolic effects of the opposite TAF-to-TDF switch are unknown. Objectives: To investigate the effect of TAF-to-TDF switch on plasma lipids, body weight, and atherosclerotic cardiovascular disease (ASCVD) risk score. Design: A retrospective chart review. Methods: One hundred and forty-six patients with TAF-to-TDF switch (Switch group) were compared with 146 patients matched for sex, age, and third antiretroviral agent class who continued unchanged TAF-containing regimen (Control group). Data were collected at approximately 1 year (follow-up FU-1) and 2 years (follow-up FU-2) after baseline values. Results: In Switch group at FU-1, total cholesterol (TC) and LDL-C decreased 12.1% and 12.4% ( P < 0.001 in both), respectively. High-density lipoprotein cholesterol (HDL-C) also decreased 8.2% ( P < 0.001) in Switch group, but TC/HDL-C ratio did not change. No statistically significant changes were observed in Control group in any lipid values. TC remained similarly decreased through FU-2 in Switch group, but LDL-C increased from FU-1 to FU-2 in both groups. ASCVD risk score decreased from 6.3% at baseline to 6.0% at FU-2 ( P = 0.012) in Switch group but increased from 8.4 to 9.1% ( P = 0.162) in Control group. Body weight increased from 83.4 kg at baseline to 84.9 kg at FU-2 ( P = 0.025) in Control group but remained stable in Switch group (83.1−83.7 kg, P = 0.978). Conclusions: TAF-to-TDF switch improved plasma lipid profile and ASCVD risk score, as well as prevented weight gain, when compared with ongoing TAF-based antiretroviral therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
3秒前
3秒前
ooseabiscuit发布了新的文献求助10
4秒前
5秒前
田田田田发布了新的文献求助30
6秒前
6秒前
6秒前
Guai发布了新的文献求助10
8秒前
酷波er应助ccq采纳,获得10
8秒前
8秒前
grace发布了新的文献求助10
9秒前
李健应助离子键采纳,获得10
9秒前
酷炫的香魔完成签到,获得积分10
9秒前
sc发布了新的文献求助10
9秒前
11秒前
远方发布了新的文献求助10
11秒前
13秒前
共享精神应助受伤的怀绿采纳,获得10
13秒前
ooseabiscuit完成签到,获得积分10
13秒前
14秒前
甜甜的寻真给甜甜的寻真的求助进行了留言
14秒前
15秒前
Perrylin718完成签到,获得积分10
16秒前
烟花应助英勇的人生采纳,获得10
16秒前
19秒前
量子星尘发布了新的文献求助10
19秒前
19秒前
韩凡完成签到,获得积分10
19秒前
CodeCraft应助飘逸的麦片采纳,获得10
20秒前
星星发布了新的文献求助10
20秒前
宋jh完成签到,获得积分10
20秒前
文文完成签到,获得积分10
20秒前
21秒前
令宏发布了新的文献求助10
21秒前
wanci应助lllllllll采纳,获得10
22秒前
23秒前
烟花应助柔弱的马里奥采纳,获得10
25秒前
田田田田完成签到,获得积分10
26秒前
27秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975339
求助须知:如何正确求助?哪些是违规求助? 3519670
关于积分的说明 11199199
捐赠科研通 3256002
什么是DOI,文献DOI怎么找? 1798043
邀请新用户注册赠送积分活动 877386
科研通“疑难数据库(出版商)”最低求助积分说明 806305